GPCM
NPSP

Granite Point Capital Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Granite Point Capital Management’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20,000
Closed -$661K – 114
2014
Q2 		$661K Sell
20,000
-21,000
-51% -$607K 0.45% 53
2014
Q1 		$1.23M Sell
41,000
-39,000
-49% -$1.34M 0.88% 33
2013
Q4 		$2.43M Buy
+80,000
New +$2.2M 0.4% 24

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Granite Point Capital Management's NPSP Position: Q3 2014 in Review

Granite Point Capital Management sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2014, closing a stake of 20,000 shares — an estimated $661K sold.

Granite Point Capital Management first reported a position in NPSP in Q4 2013 and held it in 3 quarters. The position peaked at $2.43M in Q4 2013. 200 funds tracked by Wall St. Rank hold NPSP as of Q3 2014.

  • Granite Point Capital Management reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Granite Point Capital Management sold 20,000 NPS PHARMACEUTICALS INC shares in Q3 2014, an estimated $661K.
  • Granite Point Capital Management first reported a position in NPS PHARMACEUTICALS INC in Q4 2013 and held it in 3 quarters.
  • Granite Point Capital Management's NPS PHARMACEUTICALS INC position peaked at $2.43M in Q4 2013.
  • 200 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2014.

Based on Granite Point Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.